RecruitingNCT06636201

Large-scale Multi-omics Analysis of Cerebrospinal Fluid

Deputy Director of Department of Neurosurgery, the Second Affiliated Hospital of Zhejiang University School of Medicine；Professor；

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University

Enrollment

150 participants

Start Date

Mar 1, 2024

Study Type

OBSERVATIONAL

Conditions

The aim of this study is to explore the role of cerebrospinal fluid (CSF) biomarkers in aging and neurodegenerative diseases.

Min Age: 0 YearsMax Age: 90 Years

Patients aged 0 to 90 years will be selected for the study.
Patients admitted for surgery under spinal anesthesia due to non-neurological conditions, such as lower limb fractures or hemorrhoids.
Pediatric patients undergoing surgical treatment for tethered spinal cord syndrome.

Patients with neurological conditions, including encephalitis, Parkinson's disease, Alzheimer's disease, hydrocephalus, brain tumors, and psychiatric disorders.

Interested in this trial?

Get notified about updates and connect with the research team.

The Second Affiliated Hospital, Zhejiang University School of Medicine

Hangzhou, Zhejiang, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

NCT06636201